https://www.selleckchem.com/products/sbi-115.html
0001), depressive symptoms (BDI-OR 1.2; IC 1.06-1.18; 0.0001) and level of risk exposure (annual mileage-OR 1.9; IC 1.15-3.1; = 0.007). NMAs were reported by 9.7% of patients, but more frequently by SW than SW (22.4% vs. 0.7%; χ 31, 0.0001). The occurrence of NMAs was significantly associated to ESS, BDI, habitual sleep duration and ODI ( = 0.41). SW is not predicted by severity of OSA. Evaluation of risk exposure, assessment of depressive symptoms, and reported NMA should be included in the clinical evaluation, particularly i
লাইক
মন্তব্য করুন
শেয়ার করুন
